Skip to main content
Caplight Logo









Avelo AG

Avelo AG

Private
SchlierenHealthcare & Life Scienceshttps://www.avelolife.com/

Last Round

Grant

Dec 14, 2023

Total Funding Raised

$4.17M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Avelo AG is a healthcare technology company that develops non-invasive breath sampling devices for the diagnosis of tuberculosis and lower respiratory tract infections.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

breath samplingrespiratory diagnosticsmedical devicePCR testingbreath biopsypathogen detectionnon-invasive diagnosticsmolecular diagnosticstuberculosis testingpneumonia diagnosisbreathomicsdiagnostic consumablespoint of care

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Avelo AG Comparables

Compare Avelo AG with similar companies based on industry and business-model similarity.

Avelo AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Respiratory Research, Inc.
78%
Breath Diagnostics
78%
Deep Breath Intelligence
68%

Avelo AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 14, 2023
GrantOct 26, 2023
SeedSep 20, 2022
GrantJun 22, 2022

Key People

Founding team and executive leadership

Tobias Broger

CTO and Co-Founder

Founding Team

Melanie Aregger

CEO & Co-Founder at Avelo, Co-Founder

Founding Team

Avelo AG Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 162% MoM.

  • May 18, 2026

    Monthly visitors increased 50% MoM.

Avelo AG Filings

Explore SEC and related filing metadata, where available.

Avelo AG filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Avelo AG's valuation, stock price, and market status.

Is Avelo AG a public or private company?

Avelo AG is a private company.

What is the current stock price of Avelo AG?

Avelo AG is a private company with no public stock price. No recent secondary market data is available.

How much is Avelo AG worth (valuation)?

Valuation information for Avelo AG is not publicly available.

Can I buy Avelo AG stock?

Avelo AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Avelo AG's last funding round?

Avelo AG's most recent funding round was Grant on December 14, 2023.

Who are the main investors in Avelo AG?

Key investors in Avelo AG include OCCIDENT.

Will Avelo AG IPO soon?

No public IPO plans have been announced for Avelo AG.

How can I track Avelo AG secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Avelo AG's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSchlieren
Employee Range8
Year Founded2020
Last FundingDec 14, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?